Hepatitis B Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: H26A4FFD1E59EN
Market Monitor Global

Abstracts

It means a treatment of Hepatitis B—— contagious liver infection that can be long lasting.

This report contains market size and forecasts of Hepatitis B Treatment in Global, including the following market information:

Global Hepatitis B Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hepatitis B Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Acute Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hepatitis B Treatment include Accord Healthcare Inc., Apotex Corp., Arbutus Biopharma, Bristol-Myers Squibb Company, Gilead Sciences, GlaxoSmithKline, Lupin Pharmaceuticals, Merck & Co., Inc. and Par Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis B Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatitis B Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hepatitis B Treatment Market Segment Percentages, by Type, 2021 (%)

• Acute
• Chronic

Global Hepatitis B Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hepatitis B Treatment Market Segment Percentages, by Application, 2021 (%)

• Immune Modulator Drugs
• Antiviral Drugs

Global Hepatitis B Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hepatitis B Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatitis B Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hepatitis B Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Accord Healthcare Inc.
• Apotex Corp.
• Arbutus Biopharma
• Bristol-Myers Squibb Company
• Gilead Sciences
• GlaxoSmithKline
• Lupin Pharmaceuticals
• Merck & Co., Inc.
• Par Pharmaceutical
• Teva Pharmaceuticals
• Zydus Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hepatitis B Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hepatitis B Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEPATITIS B TREATMENT OVERALL MARKET SIZE

2.1 Global Hepatitis B Treatment Market Size: 2021 VS 2028
2.2 Global Hepatitis B Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hepatitis B Treatment Players in Global Market
3.2 Top Global Hepatitis B Treatment Companies Ranked by Revenue
3.3 Global Hepatitis B Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis B Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatitis B Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis B Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Hepatitis B Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hepatitis B Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hepatitis B Treatment Market Size Markets, 2021 & 2028
  4.1.2 Acute
  4.1.3 Chronic
4.2 By Type - Global Hepatitis B Treatment Revenue & Forecasts
  4.2.1 By Type - Global Hepatitis B Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Hepatitis B Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Hepatitis B Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hepatitis B Treatment Market Size, 2021 & 2028
  5.1.2 Immune Modulator Drugs
  5.1.3 Antiviral Drugs
5.2 By Application - Global Hepatitis B Treatment Revenue & Forecasts
  5.2.1 By Application - Global Hepatitis B Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Hepatitis B Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Hepatitis B Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hepatitis B Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis B Treatment Revenue & Forecasts
  6.2.1 By Region - Global Hepatitis B Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Hepatitis B Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Hepatitis B Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hepatitis B Treatment Revenue, 2017-2028
  6.3.2 US Hepatitis B Treatment Market Size, 2017-2028
  6.3.3 Canada Hepatitis B Treatment Market Size, 2017-2028
  6.3.4 Mexico Hepatitis B Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hepatitis B Treatment Revenue, 2017-2028
  6.4.2 Germany Hepatitis B Treatment Market Size, 2017-2028
  6.4.3 France Hepatitis B Treatment Market Size, 2017-2028
  6.4.4 U.K. Hepatitis B Treatment Market Size, 2017-2028
  6.4.5 Italy Hepatitis B Treatment Market Size, 2017-2028
  6.4.6 Russia Hepatitis B Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Hepatitis B Treatment Market Size, 2017-2028
  6.4.8 Benelux Hepatitis B Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hepatitis B Treatment Revenue, 2017-2028
  6.5.2 China Hepatitis B Treatment Market Size, 2017-2028
  6.5.3 Japan Hepatitis B Treatment Market Size, 2017-2028
  6.5.4 South Korea Hepatitis B Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Hepatitis B Treatment Market Size, 2017-2028
  6.5.6 India Hepatitis B Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hepatitis B Treatment Revenue, 2017-2028
  6.6.2 Brazil Hepatitis B Treatment Market Size, 2017-2028
  6.6.3 Argentina Hepatitis B Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hepatitis B Treatment Revenue, 2017-2028
  6.7.2 Turkey Hepatitis B Treatment Market Size, 2017-2028
  6.7.3 Israel Hepatitis B Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Hepatitis B Treatment Market Size, 2017-2028
  6.7.5 UAE Hepatitis B Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Accord Healthcare Inc.
  7.1.1 Accord Healthcare Inc. Corporate Summary
  7.1.2 Accord Healthcare Inc. Business Overview
  7.1.3 Accord Healthcare Inc. Hepatitis B Treatment Major Product Offerings
  7.1.4 Accord Healthcare Inc. Hepatitis B Treatment Revenue in Global Market (2017-2022)
  7.1.5 Accord Healthcare Inc. Key News
7.2 Apotex Corp.
  7.2.1 Apotex Corp. Corporate Summary
  7.2.2 Apotex Corp. Business Overview
  7.2.3 Apotex Corp. Hepatitis B Treatment Major Product Offerings
  7.2.4 Apotex Corp. Hepatitis B Treatment Revenue in Global Market (2017-2022)
  7.2.5 Apotex Corp. Key News
7.3 Arbutus Biopharma
  7.3.1 Arbutus Biopharma Corporate Summary
  7.3.2 Arbutus Biopharma Business Overview
  7.3.3 Arbutus Biopharma Hepatitis B Treatment Major Product Offerings
  7.3.4 Arbutus Biopharma Hepatitis B Treatment Revenue in Global Market (2017-2022)
  7.3.5 Arbutus Biopharma Key News
7.4 Bristol-Myers Squibb Company
  7.4.1 Bristol-Myers Squibb Company Corporate Summary
  7.4.2 Bristol-Myers Squibb Company Business Overview
  7.4.3 Bristol-Myers Squibb Company Hepatitis B Treatment Major Product Offerings
  7.4.4 Bristol-Myers Squibb Company Hepatitis B Treatment Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Company Key News
7.5 Gilead Sciences
  7.5.1 Gilead Sciences Corporate Summary
  7.5.2 Gilead Sciences Business Overview
  7.5.3 Gilead Sciences Hepatitis B Treatment Major Product Offerings
  7.5.4 Gilead Sciences Hepatitis B Treatment Revenue in Global Market (2017-2022)
  7.5.5 Gilead Sciences Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Hepatitis B Treatment Major Product Offerings
  7.6.4 GlaxoSmithKline Hepatitis B Treatment Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Lupin Pharmaceuticals
  7.7.1 Lupin Pharmaceuticals Corporate Summary
  7.7.2 Lupin Pharmaceuticals Business Overview
  7.7.3 Lupin Pharmaceuticals Hepatitis B Treatment Major Product Offerings
  7.7.4 Lupin Pharmaceuticals Hepatitis B Treatment Revenue in Global Market (2017-2022)
  7.7.5 Lupin Pharmaceuticals Key News
7.8 Merck & Co., Inc.
  7.8.1 Merck & Co., Inc. Corporate Summary
  7.8.2 Merck & Co., Inc. Business Overview
  7.8.3 Merck & Co., Inc. Hepatitis B Treatment Major Product Offerings
  7.8.4 Merck & Co., Inc. Hepatitis B Treatment Revenue in Global Market (2017-2022)
  7.8.5 Merck & Co., Inc. Key News
7.9 Par Pharmaceutical
  7.9.1 Par Pharmaceutical Corporate Summary
  7.9.2 Par Pharmaceutical Business Overview
  7.9.3 Par Pharmaceutical Hepatitis B Treatment Major Product Offerings
  7.9.4 Par Pharmaceutical Hepatitis B Treatment Revenue in Global Market (2017-2022)
  7.9.5 Par Pharmaceutical Key News
7.10 Teva Pharmaceuticals
  7.10.1 Teva Pharmaceuticals Corporate Summary
  7.10.2 Teva Pharmaceuticals Business Overview
  7.10.3 Teva Pharmaceuticals Hepatitis B Treatment Major Product Offerings
  7.10.4 Teva Pharmaceuticals Hepatitis B Treatment Revenue in Global Market (2017-2022)
  7.10.5 Teva Pharmaceuticals Key News
7.11 Zydus Pharmaceuticals
  7.11.1 Zydus Pharmaceuticals Corporate Summary
  7.11.2 Zydus Pharmaceuticals Business Overview
  7.11.3 Zydus Pharmaceuticals Hepatitis B Treatment Major Product Offerings
  7.11.4 Zydus Pharmaceuticals Hepatitis B Treatment Revenue in Global Market (2017-2022)
  7.11.5 Zydus Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hepatitis B Treatment Market Opportunities & Trends in Global Market
Table 2. Hepatitis B Treatment Market Drivers in Global Market
Table 3. Hepatitis B Treatment Market Restraints in Global Market
Table 4. Key Players of Hepatitis B Treatment in Global Market
Table 5. Top Hepatitis B Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatitis B Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatitis B Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatitis B Treatment Product Type
Table 9. List of Global Tier 1 Hepatitis B Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hepatitis B Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatitis B Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatitis B Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hepatitis B Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatitis B Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatitis B Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hepatitis B Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatitis B Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatitis B Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatitis B Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatitis B Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatitis B Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatitis B Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatitis B Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatitis B Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatitis B Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatitis B Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatitis B Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatitis B Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Accord Healthcare Inc. Corporate Summary
Table 31. Accord Healthcare Inc. Hepatitis B Treatment Product Offerings
Table 32. Accord Healthcare Inc. Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Apotex Corp. Corporate Summary
Table 34. Apotex Corp. Hepatitis B Treatment Product Offerings
Table 35. Apotex Corp. Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Arbutus Biopharma Corporate Summary
Table 37. Arbutus Biopharma Hepatitis B Treatment Product Offerings
Table 38. Arbutus Biopharma Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Company Corporate Summary
Table 40. Bristol-Myers Squibb Company Hepatitis B Treatment Product Offerings
Table 41. Bristol-Myers Squibb Company Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Gilead Sciences Corporate Summary
Table 43. Gilead Sciences Hepatitis B Treatment Product Offerings
Table 44. Gilead Sciences Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Hepatitis B Treatment Product Offerings
Table 47. GlaxoSmithKline Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Lupin Pharmaceuticals Corporate Summary
Table 49. Lupin Pharmaceuticals Hepatitis B Treatment Product Offerings
Table 50. Lupin Pharmaceuticals Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Merck & Co., Inc. Corporate Summary
Table 52. Merck & Co., Inc. Hepatitis B Treatment Product Offerings
Table 53. Merck & Co., Inc. Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Par Pharmaceutical Corporate Summary
Table 55. Par Pharmaceutical Hepatitis B Treatment Product Offerings
Table 56. Par Pharmaceutical Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Teva Pharmaceuticals Corporate Summary
Table 58. Teva Pharmaceuticals Hepatitis B Treatment Product Offerings
Table 59. Teva Pharmaceuticals Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Zydus Pharmaceuticals Corporate Summary
Table 61. Zydus Pharmaceuticals Hepatitis B Treatment Product Offerings
Table 62. Zydus Pharmaceuticals Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hepatitis B Treatment Segment by Type in 2021
Figure 2. Hepatitis B Treatment Segment by Application in 2021
Figure 3. Global Hepatitis B Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis B Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis B Treatment Revenue in 2021
Figure 8. By Type - Global Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 12. US Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 24. China Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Accord Healthcare Inc. Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Apotex Corp. Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Arbutus Biopharma Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Company Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Gilead Sciences Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lupin Pharmaceuticals Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck & Co., Inc. Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Par Pharmaceutical Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Teva Pharmaceuticals Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Zydus Pharmaceuticals Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)